Increased plasma interleukin-8 concentrations in alcoholic hepatitis
Corresponding Author
Daniel L. B. Hill M. D.
Departments of Medicine University of Kentucky and Veterans Administration Medical Center, Lexington Kentucky 40536
Assistant Professor of Medicine, Gastroenterology Division, University of Kentucky Medical Center, Lexington, KY 40536–0084===Search for more papers by this authorLuis S. Marsano
Departments of Medicine University of Kentucky and Veterans Administration Medical Center, Lexington Kentucky 40536
Search for more papers by this authorCraig J. McClain
Departments of Medicine University of Kentucky and Veterans Administration Medical Center, Lexington Kentucky 40536
Departments of Toxicology, University of Kentucky and Veterans Administration Medical Center, Lexington Kentucky 40536
Search for more papers by this authorCorresponding Author
Daniel L. B. Hill M. D.
Departments of Medicine University of Kentucky and Veterans Administration Medical Center, Lexington Kentucky 40536
Assistant Professor of Medicine, Gastroenterology Division, University of Kentucky Medical Center, Lexington, KY 40536–0084===Search for more papers by this authorLuis S. Marsano
Departments of Medicine University of Kentucky and Veterans Administration Medical Center, Lexington Kentucky 40536
Search for more papers by this authorCraig J. McClain
Departments of Medicine University of Kentucky and Veterans Administration Medical Center, Lexington Kentucky 40536
Departments of Toxicology, University of Kentucky and Veterans Administration Medical Center, Lexington Kentucky 40536
Search for more papers by this authorAbstract
Patients with alcoholic hepatitis often have hepatic polymorphonuclear leukocyte infiltration and neutrophilia. Interleukin-8 is a cytokine that stimulates neutrophil chemotaxis and release of lysosomal enzymes. It is made by several types of cells, including fibroblasts, Kupffer cells and hepatocytes. In this study, serial plasma interleukin-8 concentrations were measured with enzyme-linked immunosorbent assay in 40 consecutive patients with moderate-to-severe alcoholic hepatitis over a 6-mo period. Two control groups included 10 patients without clinically important liver disease admitted for treatment of alcohol dependence and 12 healthy male volunteers. The mean plasma interleukin-8 level on admission was markedly increased: 695 ± 146 pg/ml in the alcoholic hepatitis patients. The alcohol-dependent control group and the normal volunteer controls had mean interleukin-8 concentrations of 106 ± 28 pg/ml and 10 ± 5 pg/ml, respectively. Initially increased interleukin-8 levels in alcoholic hepatitis patients decreased to a meals of 182 ± 42 pg/ml over the first month; levels had decreased further to 124 ± 79 pg/ml after 6 mo. Increased interleukin-8 concentrations in patients with alcoholic hepatitis suggest a role for interleukin-8 in the neutrophilia and hepatic polymorphonuclear leukocyte infiltration of alcoholic hepatitis. (HEPATOLOGY 1993;18:576–580.)
References
- 1 Paronetto F. Cell mediated immunity in liver disease. Hum Pathol 1986; 17: 168–178.
- 2 McClain CJ, Cohen DA, Dinarello CA, Cannon JG, Shedlofsky SI, Kaplan AM. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sci 1986; 39: 1479–1485.
- 3 McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. HEPATOLOGY 1989; 9: 349–351.
- 4 Sheron N, Bird G, Goka J, Alexander G, Williams R. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp Immunol 1991; 84: 449–453.
- 5 Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. HEPATOLOGY 1991; 13: 267–276.
- 6 Bird GLA, Sheron N, Goka AKJ, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990; 112: 917–920.
- 7 Felver ME, Mezey E. McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL. Plasma tumor necrosis factor α predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990; 14: 255–259.
- 8 Hill D, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain C. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 1992; 119: 547–552.
- 9 Van Zee KJ, Fischer E, Hawes AS, Hebert CA, Terrell TG, Baker JB, Lowry SF, et al. Effects of intravenous IL-8 administration on nonhuman primates. J Immunol 1992; 148: 1746–1752.
- 10 Baggiolini M, Imboden P, Detmers P. Neutrophil activation and the effects of interleukin-8/neutrophil-activating peptide 1 (IL-8/NAP-1). In: M Baggiolini, C Sorg, eds. Interleukin 8(NAP-1) and related chemotactic cytokines. Cytokines, vol 4. Basel: Karger, 1992: 1–17.
- 11 Thornton AJ, Strieter RM, Lindley I, Baggiolini M, Kunkel SL. Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. J Immunol 1990; 144: 2609–2613.
- 12 Thornton AJ, Ham J, Kunkel SL. Kupffer cell–derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures. HEPATOLOGY 1992; 15: 1112–1122.
- 13 Fogarty International Center Proceedings no. 22: Chapter 1: Hepatitis (571.1) Alcoholic hepatitis. In: CM Leevy, H Popper, S Sherlock, eds. Diseases of the liver and biliary tract: standardization of nomenclature, diagnostic criteria and diagnostic methodology. DHEW publication no. (NIH) 76–725 Washington. D.C.: U.S. Government Printing Office, 1976: 6.
- 14 Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticoeteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193–199.
- 15 Deviere J, Content J Denys C, Vandenbussche P, Schandene L, Wybran J, Dupont E. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis:correlation with IgA serum levels and lymphokines production. Clin Exp Immunol 1989; 77: 221–225.
- 16 Deviere J, Content J, Denys C, Vandenbussche P. Schandene L, Wybran J, Dupont E. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. HEPATOLOGY 1990; 11: 628–634.
- 17 Shedlofsky SI, McClain CJ. Hepatic dysfunction due to cytokins In: ES Kimball, ed. Cytokines and inflammation. Boca Raton, FL: CRC Press, 1991: 235–273.
- 18 Nagakawa J, Hishinuma I, Hirota K, Miyamoto K, Yamanaka T, Tsukidate K, Katayama K, et al. Involvement of tumor necrosis factor α in the pathogenesis of activated macrophage-mediated hepatitis. Gastroenterology 1990; 99: 758–765.
- 19 Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 1989; 38: 627–631.
- 20 Hishinuma I, Nagakawa J, Hirota K, Miyamoto K. Tsukidate K, Yamanaka T, Katayama K, et al. Tumor necrosis factor-α in galactosamine-induced hepatitis. HEPATOLOGY 1990; 12: 1187–1191.
- 21 Hill DB, Shedlofsky S, Schmidt J, Cohen D, McClain CJ. In vitro tumor necrosis factor cytotoxicity in HepG2 liver cells. In: RR Watson, ed. Proceedings of the 1992 Conference on Alcohol, Drugs of Abuse, and Immunomodulation. Vol 86. Oxford: Pergamon Press, 1993: 245–249.
- 22 Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 1987: 4: 8–14.
- 23 Bjarnason I, Ward K, Peters TJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984; 1: 179–182.
- 24 Nolan JP. Intestinal endotoxins as mediators of hepatic injury: an idea whose time has come again. HEPATOLOGY 1988; 8: 232–236.
- 25 Bigatello LM, Broitman SA, Fattori L, Di Paoli M, Pontello M, Bevilacqua G, Nespoli A. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol 1987; 82: 11–15.
- 26 Le J, Vilcek J. Biology of disease: tumor necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab Invest 1987; 56: 234–248.
- 27 Sheron N, Williams R. IL-8 as a circulating cytokine: induction by recombinant tumour necrosis factor-alpha. Clin Exp Immunol 1992; 89: 100–103.
- 28 Metinko A, Kunkel S, Standiford T, Strieter R. Anoxia-hyperoxia induces monocyte-derived interleukin-8. J Clin Invest 1992; 90: 791–798.
- 29 Honchel R, Marsano L, Cohen D, Shedlofsky S, McClain C. Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcohol Clin Exp Res 1992; 16: 665–669.
- 30 Mukaida N, Matsushima K. Regulation of IL-8 production and the characteristics of the receptors for IL-8. In: M Baggiolini, C Sorg, eds. Interleukin 8 (NAP-1) and related chemotactic cytokines. Cytokines, vol 4. Basel: Karger, 1992: 41–53.
- 31 Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med 1991; 173: 771–774.
- 32 DeForge LE, Remick DG. Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. In: Biochemical and biophysical research communications. Vol 174. Academic Press, Inc., 1991: 18–24.
- 33 Van Zee KJ, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG, Lowry SF, et al. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 1991: 146: 3478–3482.
- 34 Martich GD, Danner RL, Ceska M, Suffredini AF. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J Exp Med 1991; 173: 1021—1024.
- 35 Luscinskas FW, Cybulsky MI, Kiely J-M, Peckins CS, Davis VM, Gimbrone MA. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol 1991; 146: 1617–1625.
- 36 Revilacqua MP, Stangalin S, Gimbrone MA, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160–1165.
- 37 Wawryk SO, Novotny JR, Wicks IP, Wilkinson D, Maher D, Salvris E, Welch K, et al. The role of the LFA-1/ICAM-1 interaction in human leukocyte homing and adhesion. Immunol Rev 1989; 108: 135–161.
- 38 Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990; 4: 2868–2880.
- 39 Burra P, Hubscher S, Shaw J, Elias E, Adams D. Is the intercellular adhesion molecule- 1/leukocyte function associate antigen 1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis? Gut 1992; 33: 268–271.
- 40 Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1988; 84: 1045–1049.
- 41 Smith WB, Gamble JR, Clark-Lewis I, Vadas MA. Interleukin-8 induces neutrophil transendothelial migration. Immunol 1991; 72: 65–72.